UPBRYZIS Trademark

Trademark Overview

On Monday, November 1, 2021, a trademark application was filed for UPBRYZIS with the United States Patent and Trademark Office. The USPTO has given the UPBRYZIS trademark a serial number of 97102193. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 8, 2024. This trademark is owned by Avalo Therapeutics, Inc.. The UPBRYZIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations relating to the treatment of immunology, immune-oncology and rare genetic diseases
upbryzis

General Information

Serial Number97102193
Word MarkUPBRYZIS
Filing DateMonday, November 1, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations relating to the treatment of immunology, immune-oncology and rare genetic diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 11, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAUG THERAPEUTICS, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressCAMBRIDGE, MA 02142
Party NameAvalo Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWayne, PA 19087
Party NameAvalo Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWayne, PA 19087

Trademark Events

Event DateEvent Description
Monday, January 8, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 8, 2024ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 8, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, June 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 5, 2023SOU EXTENSION 2 GRANTED
Monday, June 5, 2023SOU EXTENSION 2 FILED
Monday, June 5, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 9, 2023SOU EXTENSION 1 GRANTED
Wednesday, December 7, 2022SOU EXTENSION 1 FILED
Wednesday, March 8, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 11, 2023NOTICE OF REVIVAL - E-MAILED
Wednesday, January 11, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, January 11, 2023PETITION TO REVIVE-GRANTED
Wednesday, January 11, 2023TEAS PETITION TO REVIVE RECEIVED
Monday, January 9, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 9, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 18, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 18, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 18, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 18, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 18, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 7, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 12, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 4, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 4, 2022ASSIGNED TO EXAMINER
Thursday, November 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 4, 2021NEW APPLICATION ENTERED

Related Keywords

upbryzis oncology rare genetic diseases immune immunology preparations relating treatment pharmaceutical